National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

volociximab (voh-loh-SIK-sih-mab)

 A monoclonal antibody that is being studied in the treatment of some types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Volociximab binds to a protein that is found on cells that line some tumor blood vessels. It is a type of angiogenesis inhibitor. Also called M200.



Previous Definitions:Vivitrol, VNP20009, VNP40101M, vocal cord, voice box
Next Definitions:Voltaren, Voltaren gel, vomit, von Hippel-Lindau syndrome, voriconazole

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov